Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 3
2000 1
2001 1
2002 1
2003 4
2004 3
2005 4
2006 5
2007 6
2008 7
2009 3
2010 3
2011 2
2012 5
2013 6
2014 8
2015 8
2016 13
2017 18
2018 24
2019 21
2020 15
2021 17
2022 19
2023 14
2024 7
2025 13
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

196 results

Results by year

Filters applied: . Clear all
Page 1
Multimorbidity and the Etiology of Schizophrenia.
Szoke A, Pignon B, Godin O, Ferchiou A, Tamouza R, Leboyer M, Schürhoff F. Szoke A, et al. Among authors: schurhoff f. Curr Psychiatry Rep. 2024 May;26(5):253-263. doi: 10.1007/s11920-024-01500-9. Epub 2024 Apr 16. Curr Psychiatry Rep. 2024. PMID: 38625632 Review.
Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs.
Fond G, Mallet J, Urbach M, Benros ME, Berk M, Billeci M, Boyer L, Correll CU, Fornaro M, Kulkarni J, Leboyer M, Llorca PM, Misdrahi D, Rey R, Schürhoff F, Solmi M, Sommer IEC, Stahl SM, Pignon B, Berna F. Fond G, et al. Among authors: schurhoff f. BMJ Ment Health. 2023 Oct;26(1):e300771. doi: 10.1136/bmjment-2023-300771. BMJ Ment Health. 2023. PMID: 37852631 Free PMC article.
Urbanicity and psychotic disorders: Facts and hypotheses.
Pignon B, Szöke A, Ku B, Melchior M, Schürhoff F. Pignon B, et al. Among authors: schurhoff f. Dialogues Clin Neurosci. 2023 Dec;25(1):122-138. doi: 10.1080/19585969.2023.2272824. Epub 2023 Nov 23. Dialogues Clin Neurosci. 2023. PMID: 37994794 Free PMC article. Review.
Searching across diagnostic boundaries.
Leboyer M, Schurhoff F. Leboyer M, et al. Among authors: schurhoff f. Schizophr Bull. 2014 Sep;40(5):946-8. doi: 10.1093/schbul/sbu112. Epub 2014 Aug 5. Schizophr Bull. 2014. PMID: 25096790 Free PMC article. No abstract available.
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques.
Bond BW, Duric B, Spinazzola E, Trotta G, Chesney E, Li Z, Quattrone D, Tripoli G, Gayer-Anderson C, Rodriguez V, Ferraro L, La Cascia C, Tarricone I, Szöke A, Arango C, Bobes J, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Rutten BPF, de Haan L, Stilo S, Schürhoff F, Pignon B, Freeman TP, Vassos E, Murray RM, Austin-Zimmerman I, Di Forti M. Bond BW, et al. Among authors: schurhoff f. Can J Psychiatry. 2025 Mar;70(3):182-193. doi: 10.1177/07067437241290187. Epub 2025 Jan 15. Can J Psychiatry. 2025. PMID: 39810593 Free PMC article.
Inflammation, childhood trauma, and symptom dimensions in schizophrenia: a path-analysis study.
Silva F, Szöke A, Lajnef M, André M, Andrieu C, Bouassida J, Boukouaci W, Berna F, Capdevielle D, Cléry M, Chéreau I, Coulon N, Clauss-Kobayashi J, Fakra E, Dorey JM, Dubertret C, Fond G, Godin O, Goze T, Leboyer M, Leignier S, Llorca PM, Mallet J, Misdrahi D, Oriol N, Rey R, Roux P, Schorr B, Tessier A, Tamouza R, Urbach M, Véry E, Wu CL; FACE-SZ (FondaMental Academic Centers of Expertise - Schizophrenia) group; Pignon B, Schürhoff F. Silva F, et al. Among authors: schurhoff f. Brain Behav Immun Health. 2025 Jul 16;48:101060. doi: 10.1016/j.bbih.2025.101060. eCollection 2025 Oct. Brain Behav Immun Health. 2025. PMID: 41049865 Free PMC article.
Comorbidity between schizophrenia and keratoconus.
Schürhoff F, Leboyer M, Szöke A. Schürhoff F, et al. Psychiatry Res. 2017 Jan;247:315-316. doi: 10.1016/j.psychres.2016.11.045. Epub 2016 Nov 30. Psychiatry Res. 2017. PMID: 27951479 No abstract available.
Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohort.
Saitoh K, Lajnef M, Boukouaci W, Andre M, Andrieu C, Aouizerate B, Barau C, Bouassida J, Capdevielle D, Chereau I, Clauss-Kobayashi J, Coulon N, Dorey JM, Dubertret C, Fakra E, Fond G, Goze T, Le Corvoisier P, Leignier S, Llorca PM, Mallet J, Misdrahi D, Oriol N, Pignon B, Rey R, Roux P, Schürhoff F, Schorr B, Urbach M, Very E, Wu CL; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) collaborators; Leboyer M, Godin O, Tamouza R. Saitoh K, et al. Among authors: schurhoff f. Psychiatry Res. 2025 Aug;350:116557. doi: 10.1016/j.psychres.2025.116557. Epub 2025 May 20. Psychiatry Res. 2025. PMID: 40460461
Clinical and inflammatory markers associated with metabolic dysfunction-associated fatty liver disease in a cohort of individuals with chronic schizophrenia (FACE-SZ).
Tokarski R, Barbosa S, Pignon B, Aouizerate B, Andrieu C, Andre M, Boukouaci W, Capdevielle D, Chereau I, Dondé C, Kobayashi JC, Dorey JM, Dubertret C, Fakra E, Fond G, Goze T, Leignier S, Llorca PM, Mallet J, Misdrahi D, Oriol N, Rey R, Roux P, Schürhoff F, Schorr B, Szöke A, Urbach M, Very E, Wu CL; FACE-SZ group; Leboyer M, Tamouza R, Godin O. Tokarski R, et al. Among authors: schurhoff f. J Psychosom Res. 2025 Aug;195:112192. doi: 10.1016/j.jpsychores.2025.112192. Epub 2025 Jun 22. J Psychosom Res. 2025. PMID: 40561671 Free article.
196 results